News About: Pharm. Industry
New business area, a priority for LG Life Sciences
LG Life Sciences will continue to adopt growth strategies next year, focusing on developing new business models.
To that end, the company said on December 21 it appointed two new business heads, Hwang Chang-hyun (s...
Choi Soo-young to receive 2006 Figure Award
Choi Soo-young, a director-general of the National Institute of Toxicological Research (NITR), was chosen as the recipient of 2006 Figure Award for his contribution to health and medical fields, the News Magazine, the...
New drug pricing plan should be taken back with no reservation
The following is a contribution by Prof. Lee Hyeong-ki, University of California Sanfrancisco (UCSF), school of pharmacy. - Ed.
The government plans to ask the national health insurance to cover only cost-effective...
Blockbuster dreams of Zydena came true.
Just within a year of its market launching Zydena has achieved a blockbuster dream in Korea by reaching the sales to a level of 10 billion or more.
Zydena was the 4th new drug that had been developed by Dong-A and ...
Hanmi to launch dexibuprofen syrup from next monthHanmi Pharm said its independently developed Maxibufen (dexibuprofen) syrup, an analgesic and antipyretic agent, will be available from January 2007.
Half dose of Maxibufen s...
|
Yuhan jointly developing test kit against germ infections.Yuhan said that the company made a joint research collaboration agreement with Busan National University on Dec. 20 for the commercialization of an infection detecting technolog...
|
Dr. Andreas Kruse to head Merck KoreaDr. Andreas Kruse, vice president of Performance& Life Science Chemicals, will succeed Dr. Bernd Reckmann, the head of Merck KGaA's Korean chemical and pharmaceutical operations...
|
Romilar supply may be suspended next year.
Bayer Healthcare announced on Dec. 20 that Romilar (dextromethorphan) tablet, an anti-cough medicine, manufactured by Roche Korea but supplied by Bayer in Korea had faced to stop supplying it in Korea due to the withd...
AZ Korea to collaborate with SNU and Seoul Asan hospitals.AstraZeneca Korea (AZ Korea) made a master agreement with SNU hospital and Seoul Asan hospital for the research collaboration of new candidated compounds for cancer treatments.
...
|
Multinational pharmaceutical firms seeking strategic alliance via co-marketing
Some foreign-invested pharmaceutical firms have actively established strategic alliances with domestic drug makers for co-marketing of new drugs to create a synergistic effect of related parties' product potenti...
